Trilaciclib: A First-in-class Therapy to Reduce Chemotherapy-induced Myelosuppression.

Autor: Young, Joanna A.1, Tan, Antoinette R.2 Antoinette.Tan@atriumhealth.org
Zdroj: touchREVIEWS in Oncology & Haematology. 2022, Vol. 18 Issue 2, p152-158. 7p.
Databáze: Academic Search Ultimate